1/
πŸ‘» AKI in patients with a kidney transplant can sometimes be β€œSCARI”

🧡Let’s talk about an approach I recently learned to some common causes of late (>3 months) allograft dysfunction to overcome the fear together #Tweetorial #NephTwitter
2/
πŸŽƒ Allograft dysfunction is defined by a rise in serum Cr of approximately 25%

πŸŽƒ It is often asymptomatic, identified on routine blood work

πŸŽƒ It can also present with nonspecific symptoms such as nausea, vomiting or diarrhea.
3/
Let's start with a not-so-SCARI case!

πŸ‘¨πŸ½ 50 y/o M with ESKD due to DM2 s/p deceased donor kidney transplant 5 yrs ago

πŸ§ͺ Cr 2.0 (176 umol/L) baseline Cr 1.3 (115 umol/L). No change in urinary frequency, amount or color. No recent illness

What kidney imaging do you suggest?
4/
πŸ—οΈ For STRUCTURAL abnormalities, ultrasound is a great noninvasive, initial modality

Abnormal Renal Resistive Index (>0.8) on doppler can be a useful, albeit nonspecific, marker of graft dysfunction
5/
πŸ’§ Hydronephrosis, lymphocele and renal artery stenosis are a few of the things to look out for

πŸ’Š Allograft dysfunction due to this category usually resolves with treatment of the underlying condition Hydronephrosis
6/
πŸ’Š CALCINEURIN inhibitor (CNI) toxicity is up next

A real Achilles heel in the transplant world, as it is secondary to the very same drugs that have made kidney transplants so successful in recent years
7/
CNI’s can cause nephrotoxicity by a few mechanisms:

πŸ•ΈοΈ Arteriolar vasoconstriction
πŸ•ΈοΈ Thrombotic microangiopathy
πŸ•ΈοΈ Hyalinization
πŸ•ΈοΈ Tubular epithelial cell vacuolization

πŸ”¬ All of which can be identified via kidney biopsy
8/
The ELITE-Symphony trial showed that use of low-dose tacrolimus is associated with

⬇️ incidence of graft dysfunction
⬆️ mean calculated GFR

compared to cyclosporine and sirolimus
nejm.org/doi/full/10.10…
9/
πŸ”Ž A trough level of the patient's CNI can help in diagnosis

⬆️ Higher serum concentration of CNI is associated with higher risk of allograft dysfunction

πŸ’Š Reduced dosing is usually the treatment of choice for acute CNI toxicity, which is often reversible
10/
πŸ™…πŸ½β€β™‚οΈ With advances in immunosuppressive therapy, ACUTE REJECTION is a lot less common than in previous years

πŸ™…πŸ½β€β™‚οΈ However, it is still considered a major risk factor for allograft failure
There are two types of acute rejection:

🚫 T cell mediated ➑️ lymphocytic infiltration of the tubules and interstitium on biopsy

🚫 Antibody mediated ➑️ presence of Donor Specific Antibodies in the serum Antibody mediated rejectionT-cell mediated rejection
πŸ’Š Treatment of TCMR involves pulse dose steroids and T-cell depletion

πŸ’Š Treatment of ABMR involves plasmapheresis, IVIG +/- Rituximab
13/
πŸ”„ Next is RECURRENT DISEASE

This cause is important to consider in patients with a primary GN as their cause for ESKD. This occurs most commonly in:

πŸ₯‡ MPGN 27-65%

πŸ₯ˆ Idiopathic Membranous Nephropathy 30-40%

πŸ₯‰ IgA nephritis 33%, FSGS 30%

cjasn.asnjournals.org/content/5/12/2…
14/
πŸ”¬ Diagnosis is made via kidney biopsy

πŸ’Š Treatment is usually the same as if the GN had occurred in a native kidney
15/
🦠 Finally, INFECTION

πŸ’€ Opportunistic viruses can also cause allograft dysfunction. Specifically, BK polyomavirus and CMV are associated with significant morbidity and graft failure
16/
🦠 BK virus is widely prevalent in the general population

⬆️ High viral load is associated with high dose immunosuppression, especially in those with multi organ transplant

⏳ Long term infection can lead to a nephropathy that can eventually lead to graft failure
17/
πŸ”Ž BK viremia is screened for via a quantitative PCR test

πŸ”¬ Diagnosis of BK nephropathy is made via biopsy

πŸ’Š Treatment involves reduction in immunosuppression dose and monitoring of viral load
18/
🦠 CMV viremia can present in two ways

πŸ₯΅ As a syndrome of fever, malaise, leukopenia

πŸ’‰ As a tissue-invasive process that can affect any organ
19/
πŸ”Ž CMV viremia is diagnosed via quantitative PCR

πŸ”¬ Kidney biopsy can identify the characteristic CMV inclusions

πŸ’Š Mild cases are treated with valganciclovir
20/
To recap, when evaluating allograft dysfunction, make sure to include this SCARI list on your differential:
πŸ—οΈ Structural abnormalities
πŸ’Š CNI toxicity
πŸ™…πŸ½β€β™‚οΈ Acute rejection
πŸ”„ Recurrent disease
🦠 Infection
21/
πŸ‘» Hopefully this topic is no longer SCARI at all! Thanks for following along. Huge shout out to @DrFlashHeart @amyaimei @Nephro_Sparks for all the help and guidance #MedTwitter #NephTwitter #Tweetorial #Kidney #Transplant #NSMC2021 @NSMCInternship

β€’ β€’ β€’

Missing some Tweet in this thread? You can try to force a refresh
γ€€

Keep Current with Mike Turk

Mike Turk Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(